plasma
-
not specified
RT-qPCR; RNase R Treatment; ROC Analysis; Bioinformatics Analysis; Clinical Sample Validation
May serve as a plasma fingerprint/marker for predicting the occurrence of GBM; used in a diagnostic risk score model with ROC AUC reported.
circ-SHPRH is up-regulated in GBM patient plasma and validated as one of three circulating circRNA fingerprints with diagnostic potential for distinguishing GBM from controls using risk score/ROC analysis.
0.559
Plasmatic circRNA Predicting the Occurrence of Human Glioblastoma.
combined biological and clinical study